Nan Fung Group Holdings as of Dec. 31, 2021
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 55 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| New Frontier Health Corp Ord Shs | 28.3 | $96M | 8.4M | 11.46 | |
| Illumina (ILMN) | 14.6 | $49M | 130k | 380.44 | |
| Harmony Biosciences Hldgs In (HRMY) | 9.7 | $33M | 769k | 42.64 | |
| Karuna Therapeutics Ord | 9.1 | $31M | 235k | 131.00 | |
| Somalogic Class A Com | 5.8 | $20M | 1.7M | 11.64 | |
| Exscientia Ads (EXAI) | 4.5 | $15M | 770k | 19.76 | |
| Eargo | 4.4 | $15M | 2.9M | 5.10 | |
| Vir Biotechnology (VIR) | 2.6 | $8.8M | 211k | 41.87 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 2.4 | $8.1M | 494k | 16.35 | |
| Seagen | 2.1 | $7.0M | 45k | 154.61 | |
| Xenon Pharmaceuticals (XENE) | 1.8 | $6.2M | 198k | 31.24 | |
| Bolt Biotherapeutics (BOLT) | 1.7 | $5.7M | 1.2M | 4.90 | |
| Beam Therapeutics (BEAM) | 1.3 | $4.4M | 55k | 79.69 | |
| New Frontier Health Corp *w Exp 11/30/202 | 1.3 | $4.3M | 1.6M | 2.70 | |
| Pacific Biosciences of California (PACB) | 1.0 | $3.5M | 172k | 20.46 | |
| Beigene Sponsored Adr (BGNE) | 0.9 | $3.0M | 11k | 270.95 | |
| Galera Therapeutics (GRTX) | 0.8 | $2.8M | 613k | 4.59 | |
| Incyte Corporation (INCY) | 0.7 | $2.5M | 35k | 73.40 | |
| Invitae (NVTAQ) | 0.7 | $2.4M | 158k | 15.27 | |
| Otonomy | 0.5 | $1.8M | 851k | 2.08 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.5 | $1.7M | 13k | 134.52 | |
| Travere Therapeutics (TVTX) | 0.4 | $1.5M | 49k | 31.03 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $1.4M | 18k | 77.82 | |
| Exelixis (EXEL) | 0.3 | $1.2M | 64k | 18.29 | |
| Sierra Oncology Com New | 0.3 | $1.2M | 53k | 21.74 | |
| Kodiak Sciences (KOD) | 0.3 | $1.1M | 13k | 84.75 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $1.0M | 79k | 13.22 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $902k | 42k | 21.50 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $818k | 35k | 23.35 | |
| Bluebird Bio (BLUE) | 0.2 | $783k | 78k | 9.99 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $659k | 7.5k | 88.34 | |
| Satsuma Pharmaceuticals Ord | 0.2 | $643k | 143k | 4.50 | |
| Dbv Technologies S A Sponsored Adr | 0.2 | $594k | 371k | 1.60 | |
| Rubius Therapeutics | 0.2 | $550k | 57k | 9.69 | |
| Dice Therapeutics | 0.1 | $499k | 20k | 25.33 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $435k | 9.3k | 46.57 | |
| Surrozen | 0.1 | $419k | 65k | 6.44 | |
| Argenx Se Sponsored Adr (ARGX) | 0.1 | $396k | 1.1k | 350.44 | |
| Kymera Therapeutics (KYMR) | 0.1 | $315k | 5.0k | 63.51 | |
| Tango Therapeutics (TNGX) | 0.1 | $279k | 26k | 10.94 | |
| Mirati Therapeutics | 0.1 | $266k | 1.8k | 146.96 | |
| Prelude Therapeutics (PRLD) | 0.1 | $253k | 20k | 12.43 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $250k | 22k | 11.26 | |
| Tscan Therapeutics (TCRX) | 0.1 | $219k | 49k | 4.51 | |
| Reata Pharmaceuticals Cl A | 0.1 | $218k | 8.3k | 26.38 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $215k | 16k | 13.83 | |
| Amryt Pharma Sponsored Ads | 0.1 | $207k | 19k | 10.81 | |
| Day One Biopharmaceuticals I (DAWN) | 0.1 | $193k | 11k | 16.86 | |
| Abcellera Biologics (ABCL) | 0.1 | $188k | 13k | 14.26 | |
| Atyr Pharma Com New (ATYR) | 0.1 | $176k | 24k | 7.49 | |
| Synlogic | 0.0 | $166k | 69k | 2.42 | |
| Kura Oncology (KURA) | 0.0 | $163k | 12k | 13.99 | |
| Dyne Therapeutics (DYN) | 0.0 | $138k | 12k | 11.87 | |
| Vincerx Pharma Com New (VINC) | 0.0 | $113k | 11k | 10.23 | |
| Amarin Corp Spons Adr New (AMRN) | 0.0 | $94k | 28k | 3.37 |
